Marcos Calderon, M.D.
NPI 1306827423ActiveIndividual· Nuclear Medicine· Houston, TX
Nuclear Medicine (M.D.) in Houston, Texas, licensed in TX, with an NPI issued in November 2005. Part D covered 40 prescriptions written in 2024, 75% of them generic. Telix Pharmaceuticals reported $47.36 in payments in 2025, mostly food and beverage.
Overview
| NPI | 1306827423 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Nov 7, 2005 |
| Last updated in NPPES | Jul 8, 2007 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Nuclear Medicine Primary | 207U00000X | E0226 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|
Part D prescriptions in 2024
| Prescriptions (claims) | 40 · 87 30-day fills |
|---|---|
| Total drug cost | $8,310 |
| Generic share | 75% of claims |
Industry payments (Open Payments)
- 2025$47.36 · 1 payment from 1 company
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Telix Pharmaceuticals | $47.36 | 1 |
What the 2025 payments were for
- Food and Beverage$47.36 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Nuclear Medicine providers in Houston
- 1144263849
- 1629293808
- 1164455473
- 1346449147
- 1194344457
- 1578980769
- 1639164809
- 1578575973
- 1841483385
- 1861898728
- 1780839183
- 1982850657